When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZYME - Wainwright sees 310% upside in Outlook Therapeutics in premarket analyst action
Zymeworks Inc.
Outlook Therapeutics (NASDAQ:OTLK) initiated with Buy rating and $8 (310% upside) at H.C. Wainwright. Shares up 11% premarket.
More news on: Outlook Therapeutics, Inc., Blueprint Medicines Corporation, Deciphera Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ,